Pfizer Venture Investments

New York

Founded:2004

Firm Location:New York • Connecticut • New York, New York • New York City

Pfizer Venture Investments Team

Photo of Rana Al-Hallaq, Partner at Pfizer Venture Investments

Pfizer Venture Investments·Partner

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in New York City

Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in New York City (Other Lists)

to see your intro paths to Rana

Photo of Michael Baran, Partner at Pfizer Venture Investments

Pfizer Venture Investments·Partner

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in New York City

Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in New York City (Other Lists)

to see your intro paths to Michael

Photo of Barbara Dalton, Vice President at Pfizer Venture Investments

Pfizer Venture Investments·Vice President

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in New York (NY)

Investors in New York City (Other Lists)

to see your intro paths to Barbara

Photo of Christopher O'Donnell, Partner at Pfizer Venture Investments

Christopher O'Donnell

Pfizer Venture Investments·Partner

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in Connecticut

Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B)

to see your intro paths to Christopher

Photo of Denis Patrick, Vice President at Pfizer Venture Investments

Pfizer Venture Investments·Vice President

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in New York

Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B)

to see your intro paths to Denis

Photo of Nikola Trbovic, Partner at Pfizer Venture Investments

Pfizer Venture Investments·Partner

Sweet spot: $10.0M

Range: $100K - $15.0M

Investors in New York City

Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Diverse Investors (Other Lists), Investors in New York City (Other Lists)

to see your intro paths to Nikola